Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study)
Clinical trial NCT00770081 · COMPLETED
Trial details
- NCT number
- NCT00770081
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2011-04-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.